Differential reduction of HCN channel activity by various types of lipopolysaccharide

Journal of Molecular and Cellular Cardiology

Volumn 51, Issue 2, 2011, Pages 226-235

  Klöckner, Udo ^a   Rueckschloss, Uwe ^a   Grossmann, Claudia ^a   Ebelt, Henning ^b   Müller Werdan, Ursula ^b   Loppnow, Harald ^b   Werdan, Karl ^b   Gekle, Michael ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

Author keywords

HCN channel; Heart rate variability; Lipopolysaccharide; O chain; Pacemaker cell; Sepsis

Indexed keywords

HYPERPOLARIZATION ACTIVATED CYCLIC NUCLEOTIDE GATED CHANNEL 2; HYPERPOLARIZATION ACTIVATED CYCLIC NUCLEOTIDE GATED CHANNEL 4; ION CHANNEL; LIPOPOLYSACCHARIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STRAIN HEK293; CHANNEL GATING; CONTROLLED STUDY; DIASTOLE; HEART DEPOLARIZATION; HUMAN; HUMAN CELL; ION CONDUCTANCE; ION CURRENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINUS NODE;

MURINAE;

EID: 79959504566     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2011.05.004     Document Type: Article

References (46)

1. Parrillo J.E. The cardiovascular pathophysiology of sepsis. Annu Rev Med 2003, 40:469-485.
2. Court O., Kumar A., Parrillo J.E., Kumar A. Clinical review: myocardial depression in sepsis and septic shock. Crit Care 2002, 6:500-508.
3. Werdan K., Schmidt H., Ebelt H., Zorn-Pauly K., Koidl B., Hoke R.S., et al. Impaired regulation of cardiac function in sepsis, SIRS, and MODS. Can J Physiol Pharmacol 2009, 87:266-274.
4. Zhang T., Feng Q.P. Nitric oxide and calcium signaling regulate myocardial tumor necrosis factor-alpha expression and cardiac function in sepsis. Can J Physiol Pharmacol 2010, 88:92-104.
5. Loppnow H., Brade H., Durrbaum I., Dinarello C.A., Kusumoto S., Rietschel E.T., et al. Il-1 induction-capacity of defined lipopolysaccharide partial structures. J Immunol 1989, 142:3229-3238.
6. Raetz C.R.H. Biochemistry of endotoxins. Annu Rev Biochem 1990, 59:129-170.
7. Rietschel E.T., Kirikae T., Schade F.U., Mamat U., Schmidt G., Loppnow H., et al. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 1994, 8:217-225.
8. Schmidt H., Saworski J., Werdan K., Muller-Werdan U. Decreased beating rate variability of spontaneously contracting cardiomyocytes after co-incubation with endotoxin. J Endotoxin Res 2007, 13:339-342.
9. Zorn-Pauly K., Pelzmann B., Lang P., Machler H., Schmidt H., Ebelt H., et al. Endotoxin impairs the human pacemaker current If. Shock 2007, 28:655-661.
10. Gauss R., Seifert R., Kaupp U.B. Molecular identification of a hyperpolarization-activated channel in sea urchin sperm. Nature 1998, 393:583-587.
11. Ludwig A., Zong X.G., Jeglitsch M., Hofmann F., Biel M. A family of hyperpolarization-activated mammalian cation channels. Nature 1998, 393:587-591.
12. Santoro B., Liu D.T., Yao H., Bartsch D., Kandel E.R., Siegelbaum S.A., et al. Identification of a gene encoding a hyperpolarization-activated pacemaker channel of brain. Cell 1998, 93:717-729.
13. Biel M., Wahl-Schott C., Michalakis S., Zong X.G. Hyperpolarization-activated cation channels: from genes to function. Physiol Rev 2009, 89:847-885.
14. Stillitano F., Lonardo G., Zicha S., Varro A., Cerbai E., Mugelli A., et al. Molecular basis of funny current (If) in normal and failing human heart. J Mol Cell Cardiol 2008, 45:289-299.
15. Shi W., Wymore R., Yu H., Wu J., Wymore R.T., Pan Z., et al. Distribution and prevalence of hyperpolarization-activated cation channel (HCN) mRNA expression in cardiac tissues. Circ Res 1999, 85:e1-e6.
16. Stieber J., Stockl G., Herrmann S., Hassfurth B., Hofmann F. Functional expression of the human HCN3 channel. J Biol Chem 2005, 280:34635-34643.
17. DiFrancesco D., Ferroni A., Mazzanti M., Tromba C. Properties of the hyperpolarizing-activated current (if) in cells isolated from the rabbit sino-atrial node. J Physiol 1986, 377:61-88.
18. DiFrancesco D. A study of the ionic nature of the pace-maker current in calf Purkinje fibres. J Physiol 1981, 314:377-393.
19. Ludwig A., Zong X., Stieber J., Hullin R., Hofmann F., Biel M. Two pacemaker channels from human heart with profoundly different activation kinetics. EMBO J 1999, 18:2323-2329.
20. Moroni A., Barbuti A., Altomare C., Viscomi C., Morgan J., Baruscotti M., et al. Kinetic and ionic properties of the human HCN2 pacemaker channel. Pflugers Arch 2000, 439:618-626.
21. Medzhitov R., PrestonHurlburt P., Janeway C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 388:394-397.
22. Chen L., Frister A., Wang S., Ludwig A., Behr H., Pippig S., et al. Interaction of vascular smooth muscle cells and monocytes by soluble factors synergistically enhances IL-6 and MCP-1 production. Am J Physiol Heart Circ Physiol 2009, 296:H987-H996.
23. Van Snick J., Cayphas S., Vink A., Uyttenhove C., Coulie P.G., Rubira M.R., et al. Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. Proc Natl Acad Sci USA 1986, 83:9679-9683.
24. Hitchcock P.J., Leive L., Makela P.H., Rietschel E.T., Strittmatter W., Morrison D.C. Lipopolysaccharide nomenclature - past, present, and future. J Bacteriol 1986, 166:699-705.
25. Loppnow H., Brade H., Rietschel E.T., Flad H.D. Induction of cytokines in mononuclear and vascular cells by endotoxin and other bacterial products. Methods Enzymol 1994, 236:3-10.
26. Brioschi C., Micheloni S., Tellez J.O., Pisoni G., Longhi R., Moroni P., et al. Distribution of the pacemaker HCN4 channel mRNA and protein in the rabbit sinoatrial node. J Mol Cell Cardiol 2009, 47:221-227.
27. Nof E., Antzelevitch C., Glikson M. The contribution of HCN4 to normal sinus node function in humans and animal models. Pacing Clin Electrophysiol 2010, 33:100-106.
28. DiFrancesco D. The role of the funny current in pacemaker activity. Circ Res 2010, 106:434-446.
29. Meng Q.T., Xia Z.Y., Liu J., Bayliss D.A., Chen X. Local anesthetic inhibits hyperpolarization-activated cationic currents. Mol Pharmacol 2011, 79:866-873.
30. Ludwig A., Budde T., Stieber J., Moosmang S., Wahl C., Holthoff K., et al. Absence epilepsy and sinus dysrhythmia in mice lacking the pacemaker channel HCN2. EMBO J 2003, 22:216-224.
31. DiFrancesco D., Tromba C. Acetylcholine inhibits activation of the cardiac hyperpolarizing-activated current, If. Pflugers Arch 1987, 410:139-142.
32. DiFrancesco D., Tortora P. Direct activation of cardiac-pacemaker channels by intracellular cyclic-AMP. Nature 1991, 351:145-147.
33. Lyashchenko A.K., Redd K.J., Yang J., Tibbs G.R. Propofol inhibits HCN1 pacemaker channels by selective association with the closed states of the membrane embedded channel core. J Physiol 2007, 583:37-56.
34. Chow J.C., Young D.W., Golenbock D.T., Christ W.J., Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 1999, 274:10689-10692.
35. Herrmann S., Stieber J., Stockl G., Hofmann F., Ludwig A. HCN4 provides a "depolarization reserve" and is not required for heart rate acceleration in mice. EMBO J 2007, 26:4423-4432.
36. Whitaker G.M., Angoli D., Nazzari H., Shigemoto R., Accili E.A. HCN2 and HCN4 isoforms self-assemble and co-assemble with equal preference to form functional pacemaker channels. J Biol Chem 2007, 282:22900-22909.
37. Zhang Q., Huang A., Lin Y.C., Yu H.G. Associated changes in HCN2 and HCN4 transcripts and If pacemaker current in myocytes. Biochim Biophys Acta 2009, 1788:1138-1147.
38. Stengl M., Bartak F., Sykora R., Chvojka J., Benes J., Krouzecky A., et al. Reduced L-type calcium current in ventricular myocytes from pigs with hyperdynamic septic shock. Crit Care Med 2010, 38:579-587.
39. Zhang X.H., Li G.R., Bourreau J.P. The effect of adrenomedullin on the L-type calcium current in myocytes from septic shock rats: signaling pathway. Am J Physiol Heart Circ Physiol 2007, 293:H2888-H2893.
40. Holst O., Ulmer A.J., Brade H., Flad H.D., Rietschel E.T. Biochemistry and cell biology of bacterial endotoxins. FEMS Immunol Med Microbiol 1996, 16:83-104.
41. Schmidt H.M., Hoyer D.P., Hennen R., Heinroth K., Rauchhaus M.M., Prondzinsky R.M., et al. Autonomic dysfunction predicts both 1- and 2-month mortality in middle-aged patients with multiple organ dysfunction syndrome. Crit Care Med 2008, 36:967-970.
42. Galletly D.C., Buckley D.H.F., Robinson B.J., Corfiatis T. Heart rate variability during propofol anaesthesia. Br J Anaesth 1994, 72:219-220.
43. Deutschman C.S., Harris A.P., Fleisher L.A. Changes in heart rate variability under propofol anesthesia. Anesth Analg 1994, 79:373-377.
44. Ying S.W., Abbas S.Y., Harrison N.L., Goldstein P.A. Propofol block of Ih contributes to the suppression of neuronal excitability and rhythmic burst firing in thalamocortical neurons. Eur J Neurosci 2006, 23:465-480.
45. Chen X., Sirois J.E., Lei Q., Talley E.M., Lynch C., Bayliss D.A. HCN subunit-specific and cAMP-modulated effects of anesthetics on neuronal pacemaker currents. J Neurosci 2005, 25:5803-5814.
46. Galletly D.C., Westenberg A.M., Robinson B.J., Corfiatis T. Effect of halothane, isoflurane and fentanyl on spectral components of heart rate variability. Br J Anaesth 1994, 72:177-180.